Related Experiment Video
Updated: Dec 9, 2025
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.8K
Advances in Neonatal Infections
Avroy A Fanaroff1, Jonathan M Fanaroff1
1Division of Neonatology, Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, Ohio.
American Journal of Perinatology
|September 8, 2020
Summary
Neonatal sepsis is a major cause of infant mortality, with challenges from resistant bacteria and emerging viruses. Future treatments may involve stem cell therapy and novel antimicrobials to combat this critical public health issue.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Public Health
Background:
- Neonatal sepsis is a significant global cause of infant mortality, particularly in developing nations.
- Despite advances, it remains a critical public health concern, accounting for a substantial portion of deaths in children under five.
- The emergence of antibiotic-resistant bacteria and novel viruses presents ongoing challenges in managing neonatal infections.
Purpose of the Study:
- To review advances in the diagnosis, prevention, and treatment of neonatal sepsis.
- To highlight current challenges, including antimicrobial resistance and emerging viral threats.
- To explore potential future therapeutic strategies for neonatal sepsis.
Main Methods:
- Review of diagnostic advancements, including improved culture techniques, polymerase chain reaction (PCR), and biologic markers.
- Analysis of therapeutic progress, encompassing antibiotics, antifungals, antivirals, immunotherapy, and infection prevention bundles.
- Discussion of evolving challenges like bacterial resistance and new viral pathogens.
Main Results:
- Diagnostic capabilities have improved with faster confirmation methods and better infection markers.
- Therapeutic options have expanded, alongside enhanced prevention strategies like hand hygiene and antibiotic stewardship.
- Emerging resistant bacteria and viruses (e.g., HIV, Zika, COVID-19) pose persistent threats.
Conclusions:
- Hand hygiene is crucial for preventing late-onset sepsis.
- Future treatments may include stem cell therapy, antimicrobial peptides, and targeting pattern recognition receptors.
- Modulating the infant microbiome, favoring maternal milk and judicious antibiotic use, is a key future goal.
Related Concept Videos
01:22Development of Immunocompetence
612
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
612
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
183
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
183
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
5.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.2K
01:30Pneumonia III: Complications and Assessment
672
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
672
01:28Pneumonia IV: Management
636
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
636